| Date Filed | Type | Description |
| 10/06/2023 |
4
| SAPIRSTEIN JAMES (President and CEO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Sold 2,764 shares
@ $0.29, valued at
$801.6 |
|
| 07/05/2023 |
4
| SAPIRSTEIN JAMES (President and CEO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Sold 3,349 shares
@ $1.54, valued at
$5.2k
|
|
| 06/01/2023 |
4
| SAPIRSTEIN JAMES (Director) has filed a Form 4 on Blue Water Biotech, Inc.|
Txns:
| Granted 6,360 shares
@ $0 |
|
| 04/05/2023 |
4
| SAPIRSTEIN JAMES (President and CEO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Sold 3,347 shares
@ $2.5, valued at
$8.4k
|
|
| 04/04/2023 |
4
| SAPIRSTEIN JAMES (Director) has filed a Form 4 on Enochian Biosciences Inc|
Txns:
| Granted 64,655 options to buy
@ $1.16, valued at
$75k
|
|
| 01/17/2023 |
3
| SAPIRSTEIN JAMES (Director) has filed a Form 3 on ZyVersa Therapeutics, Inc. |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| SAPIRSTEIN JAMES (Director) has filed a Form 4 on Blue Water Vaccines Inc.|
Txns:
| Granted 50,575 options
@ $6.45, valued at
$326.2k
|
|
| 02/23/2022 |
3
| SAPIRSTEIN JAMES (Director) has filed a Form 3 on Blue Water Vaccines Inc. |
| 01/03/2022 |
4
| SAPIRSTEIN JAMES (PRES, CEO & CHAIRMAN OF BOARD) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.45, valued at
$217.5k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
3
| SAPIRSTEIN JAMES (Director) has filed a Form 3 on Blue Water Acquisition Corp. |
| 09/10/2020 |
3
| SAPIRSTEIN JAMES (Interim Chief Executive Office) has filed a Form 3 on MARIZYME INC |
| 07/20/2020 |
4
| SAPIRSTEIN JAMES (PRESIDENT AND CEO) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Granted 1,200,000 options to buy
@ $0.85, valued at
$1M
Granted 13 convertible preferred
@ $0
Granted 64,935 options to buy
@ $0.85, valued at
$55.2k
|
|
| 10/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/26/2019 |
4
| SAPIRSTEIN JAMES (Director) has filed a Form 4 on Enochian Biosciences Inc|
Txns:
| Granted 9,173 options to buy
@ $6.25, valued at
$57.3k
|
|
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/04/2018 |
3
| SAPIRSTEIN JAMES (Director) has filed a Form 3 on Enochian Biosciences Inc |
| 01/05/2018 |
4
| SAPIRSTEIN JAMES (CEO) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.|
Txns:
| Granted 322,092 shares
@ $0 |
|
| 12/12/2017 |
4
| SAPIRSTEIN JAMES (Director) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Acquired 38,114 options to buy
@ $1.45, valued at
$55.3k
|
|
| 07/07/2017 |
4
| SAPIRSTEIN JAMES (CEO) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.|
Txns:
| Granted 141,061 shares
@ $0 |
|
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2017 |
4
| SAPIRSTEIN JAMES (CEO) has filed a Form 4 on ContraVir Pharmaceuticals, Inc. |
| 02/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/15/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 01/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/31/2016 |
4
| SAPIRSTEIN JAMES (CEO) has filed a Form 4 on ContraVir Pharmaceuticals, Inc. |
| 06/14/2016 |
4
| SAPIRSTEIN JAMES (CEO) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.|
Txns:
| Granted 500,000 options
@ $0.99, valued at
$495k
|
|
| 04/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/18/2016 |
4
| SAPIRSTEIN JAMES (CEO) has filed a Form 4 on ContraVir Pharmaceuticals, Inc. |
| 11/09/2012 |
4
| SAPIRSTEIN JAMES (CEO) has filed a Form 4 on Alliqua, Inc.|
Txns:
| Granted 9,286,408 options to buy
@ $0.1, valued at
$928.6k
Granted 3,095,469 options to buy
@ $0 |
|